Aslan Pharmaceuticals enters into a strategic collaboration with IQVIA
ASLAN Pharmaceuticals announced the appointment of IQVIA Biotech, a provider of analytics, technology solutions, and clinical research services to the life sciences industry, as its preferred clinical research organisation for logistics related to decentralised clinical trials, comprising the global oversight, expansion and engagement of patients for trials associated with the clinical development of ASLAN004 and ASLAN003.
IQVIA Biotech will proffer patient recruitment, clinical monitoring, medical writing and biostatistics for ASLAN’s upcoming 300-patient Phase 2b trial of ASLAN0...
